Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
Hernández D et al. |
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. |
2007 |
Transplantation |
pmid:17893603
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
Qi S et al. |
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates. |
2003 |
Transplantation |
pmid:12717189
|
Singh N et al. |
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. |
2000 |
Transplantation |
pmid:10708096
|
Haririan A et al. |
Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. |
2003 |
Transplantation |
pmid:12717201
|
Gonwa T et al. |
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. |
2003 |
Transplantation |
pmid:12717205
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Kato T et al. |
Rhabdomyolysis after kidney transplantation caused by elevated serum cyclosporine due to metabolic enzyme and transporters disorder. |
2011 |
Transplantation |
pmid:21747275
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Stegall MD et al. |
Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. |
1997 |
Transplantation |
pmid:9422404
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Sampaio MS et al. |
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. |
2012 |
Transplantation |
pmid:22129761
|
Al-Uzri A et al. |
Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). |
2001 |
Transplantation |
pmid:11579294
|
Tory R et al. |
Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations. |
2009 |
Transplantation |
pmid:19584682
|
Weiler N et al. |
Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial. |
2010 |
Transplantation |
pmid:21048536
|
Chisholm MA et al. |
Renal transplant patient compliance with free immunosuppressive medications. |
2000 |
Transplantation |
pmid:11063348
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Hoogduijn MJ et al. |
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. |
2008 |
Transplantation |
pmid:19005411
|
Heidt S et al. |
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. |
2008 |
Transplantation |
pmid:19005412
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Tzakis AG et al. |
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. |
2004 |
Transplantation |
pmid:15114087
|
Bechstein WO et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. |
2004 |
Transplantation |
pmid:15114089
|
Talbot D et al. |
Alopecia as a consequence of tacrolimus therapy in renal transplantation? |
1997 |
Transplantation |
pmid:9415574
|
Gregory CR et al. |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. |
1995 |
Transplantation |
pmid:7533955
|
Demmers MW et al. |
Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. |
2014 |
Transplantation |
pmid:24157471
|
Gill JS et al. |
Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. |
2010 |
Transplantation |
pmid:20098280
|
Pascual J et al. |
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
2009 |
Transplantation |
pmid:19136902
|
Suzuki S et al. |
Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7685932
|
Lauria MW et al. |
Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations. |
2010 |
Transplantation |
pmid:20061923
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Pascual M et al. |
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. |
1998 |
Transplantation |
pmid:9869086
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Krook H et al. |
Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. |
2002 |
Transplantation |
pmid:12438951
|
Baran DA et al. |
Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol. |
2002 |
Transplantation |
pmid:12438960
|
Blaheta RA et al. |
Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. |
2000 |
Transplantation |
pmid:10830246
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Ciancio G et al. |
A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. |
2013 |
Transplantation |
pmid:23903014
|
Yuzawa K and Fukao K |
Topical FK506 ointment for skin grafting. |
1998 |
Transplantation |
pmid:9565111
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10919600
|
Zieliński A et al. |
Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. |
2003 |
Transplantation |
pmid:12923442
|
Markus PM et al. |
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. |
1991 |
Transplantation |
pmid:1718063
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|